bevacizumab,relugolix,RGX-202-01
roche,sumitovant biopharma,Inspirna
second-line rgx-202-01 plus folfiri/bevacizumab shows early efficacy, safety in kras-mutant crc #esmogi22 #esmogi #crcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.